The Parker Institute for Cancer Immunotherapy enables real collaboration, accelerating ambitious research to deliver new immunotherapies engineered to save lives.
World-renowned experts from leading cancer centers are at the forefront of our research.
Open in Twitter Parker Institute @parkerici RT @KatieEYost: Thrilled to share our preprint characterizing clonal T cell dynamics in response to PD-1 blockade with @Satpathology, Anne… 19 hours ago
Open in Twitter Parker Institute @parkerici RT @Satpathology: Excited to share our preprint tracking the T cell response to PD-1 blockade in patients using single-cell RNA/TCR-seq! T… 19 hours ago